NLRP3 and cryopyrin-associated periodic syndrome: All these CAPS associated NLRP3 pathogenic variants are gain of function leading to an hyperactivation of NLRP3 inflammasome, an increased secretion and release of pro-inflammatory cytokines and tissue damage related to disease symptoms.